Abstract
Stem cells exert therapeutic effects for central nervous system (CNS) trauma. Accumulating evidence reveals that stem cell-based therapies for CNS trauma can be achieved via transplantation of exogenous stem cells or stimulation of endogenous stem cells from the neurogenic niches of subventricular zone and subgranular zone, or recruited from the bone marrow through peripheral circulation. In this chapter, we review the different sources of stem cells that have been tested in animal models of CNS trauma, highlighting the research progress on stem cell-based therapeutics in stroke and their extension to traumatic brain injury (TBI). In addition, we discuss specific mechanisms of action, in particular neurovascular repair by endothelial progenitor cells, as key translational research for advancing the clinical applications of stem cells for CNS trauma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Faul M, Xu L, Wald MM, Coronado VG (2010) Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlanta, GA
Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (2003) Report to Congress on mild traumatic brain injury in the United States: steps to prevent a serious public health problem. Centers for Disease Control and Prevention, Atlanta, GA
Brooks A, Lindstrom J, McCray J et al (1995) Cost of medical care for a population-based sample of persons surviving traumatic brain injury. J Head Trauma Rehabil 10:1–13
Oladunjoye AO, Schrot RJ, Zwienenberg-Lee M, Muizelaar JP, Shahlaie K (2013) Decompressive craniectomy using gelatin film and future bone flap replacement. J Neurosurg 118(4):776–782
Swadron SP, LeRoux P, Smith WS, Weingart SD (2012) Emergency neurological life support: traumatic brain injury. Neurocrit Care 17:S112–S121
Farahvar A, Gerber LM, Chiu YL, Carney N, Hartl R, Ghajar J (2012) Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring. J Neurosurg 117:729–734
Bor-Seng-Shu E, Figueiredo EG, Amorim RL, Teixeira MJ, Valbuza JS, de Oliveira MM, Panerai RB (2012) Decompressive craniectomy: a meta-analysis of influences on intracranial pressure and cerebral perfusion pressure in the treatment of traumatic brain injury. J Neurosurg 117:589–596
Bor-Seng-Shu E, Figueiredo EG, Fonoff ET, Fujimoto Y, Panerai RB, Teixeira MJ (2013) Decompressive craniectomy and head injury: brain morphometry, ICP, cerebral hemodynamics, cerebral microvascular reactivity, and neurochemistry. Neurosurg Rev 36(3):361–370
Brasure M, Lamberty GJ, Sayer NA, Nelson NW, MacDonald R, Ouellette J, Tacklind J, Grove M, Rutks IR, Butler ME, Kane RL, Wilt TJ (2012) Multidisciplinary postacute rehabilitation for moderate to severe traumatic brain injury in adults [internet]. Agency for Healthcare Research and Quality (US), Rockville, MD
Brasure M, Lamberty GJ, Sayer NA, Nelson NW, Macdonald R, Ouellette J, Wilt TJ (2013) Participation after multidisciplinary rehabilitation for moderate to severe traumatic brain injury in adults: a systematic review. Arch Phys Med Rehabil 94(7):1398–1420
Krawczyk DC, Marquez de la Plata C, Schauer GF, Vas AK, Keebler M, Tuthill S, Gardner C, Jantz T, Yu W, Chapman SB (2013) Evaluating the effectiveness of reasoning training in military and civilian chronic traumatic brain injury patients: study protocol. Trials 14:29
Brown JM, Deriso DM, Tansey KE (2012) From contemporary rehabilitation to restorative neurology. Clin Neurol Neurosurg 114:471–474
Ploughman M (2008) Exercise is brain food: the effects of physical activity on cognitive function. Dev Neurorehabil 11:236–240
Zafonte RD, Bagiella E, Ansel BM, Novack TA, Friedewald WT, Hesdorffer DC, Timmons SD, Jallo J, Eisenberg H, Hart T, Ricker JH, Diaz-Arrastia R, Merchant RE, Temkin NR, Melton S, Dikmen SS (2012) Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: citicoline brain injury treatment trial (COBRIT). JAMA 308:1993–2000
Sánchez-Aguilar M, Tapia-Pérez JH, Sánchez-Rodríguez JJ, Viñas-Ríos JM, Martínez-Pérez P, de la Cruz-Mendoza E, Sánchez-Reyna M, Torres-Corzo JG, Gordillo-Moscoso A (2013) Effect of rosuvastatin on cytokines after traumatic head injury. J Neurosurg 118:669–675
McConeghy KW, Hatton J, Hughes L, Cook AM (2012) A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs 26:613–636
Stein DG (2013) A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm Behav 63:291–300
Stein SC et al (2009) Erythrocyte-bound tissue plasminogen activator is neuroprotective in experimental traumatic brain injury. J Neurotrauma 26:1585–1592
Fox JL, Vu EN, Doyle-Waters M, Brubacher JR, Abu-Laban R, Hu Z (2010) Prophylactic hypothermia for traumatic brain injury: a quantitative systematic review. CJEM 12:355–364
Joan Abbott N, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ (2010) Structure and function of the blood–brain barrier. Neurobiol Dis 37:13–25
Gaetz M (2004) The neurophysiology of brain injury. Clin Neurophysiol 115(1):4–18
Zweckberger K et al (2006) Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J Neurotrauma 23:1083–1093
Rhodes J (2011) Peripheral immune cells in the pathology of traumatic brain injury? Curr Opin Crit Care 17:122–130
Beaumont A et al (2006) Bolus tracer delivery measured by MRI confirms edema without blood–brain barrier permeability in diffuse traumatic brain injury. Acta Neurochir Suppl 96:171–174
Soares HD, Hicks RR, Smith D, McIntosh TK (1995) Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15:8223–8233
Toda H, Takahashi J, Iwakami N (2001) Grafting neural cells improved the impaired spatial recognition in ischemic rats. Neurosci Lett 31:9–12
Ferrari A, Ehler E, Nitsch RM, Gotz J (2000) Immature human NT2 cells grafted into mouse brain differentiate into neuronal and glial cell types. FEBS Lett 486:121–125
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR (1998) Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149:310–321
Veizovic T, Beech JS, Stroemer PR, Watson WP, Hodges H (2001) Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 32:1012–1019
Modo M, Stroemer RP, Tang E, Veizovic T, Sowniski P, Hodges H (2000) Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J Neurosci Methods 104:99–109
Englund U, Bjorklund A, Wictorin K, Lindvall O, Kokaia M (2002) Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc Natl Acad Sci U S A 99:17089–17094
Kopen GC, Prockop DJ, Phinney DG (1999) Marrow stromal cells migrate through out forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96:10711–10716
Chen J, Li Y, Chopp M (2000) Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39:711–716
Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu XY, Zhang Z (2000) Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20:1311–1319
Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364–370
Munoz-Elias G, Marcus AJ, Coyne M, Woodbury D, Black IB (2004) Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J Neurosci 24:4585–4595
Borlongan CV, Hadman M, Davis C, Sanberg PR (2004) CNS entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35:2385–2389
Eglitis MA, Mezey E (1997) Hematopoietic cell differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 94:4080–4085
Li Y, Chen J, Wang L, Lu M, Chopp M (2001) Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56:1666–1672
Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682–2688
Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, Carothers J (2002) Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33:1362–1368
Willing AE, Milliken M, Poulos S, Zigova T, Song S, Davis CD et al (2003) Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 73:296–307
Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC et al (2003) Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92:692–699
Ma H et al (2012) Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem Res 37:69–83
Mahmood A et al (2006) Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg 104:272–277
Qu C et al (2008) Treatment of traumatic brain injury in mice with marrow stromal cells. Brain Res 1208:234–239
Lu D et al (2007) Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery 61:596–602
Harting MT et al (2009) Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 110:1189–1197
Riess P et al (2002) Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 51:1043–1054
Hattiangady B, Shetty AK (2012) Neural stem cell grafting counteracts hippocampal injury-mediated impairments in mood, memory, and neurogenesis. Stem Cells Transl Med 1:696–708
Nichols JE et al (2013) Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2 + CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury. Stem Cell Res Ther 4:3
Yan ZJ et al (2013) Neural stem-like cells derived from human amnion tissue are effective in treating traumatic brain injury in rat. Neurochem Res 38(5):1022–1033
Wallenquist U et al (2012) Ibuprofen attenuates the inflammatory response and allows formation of migratory neuroblasts from grafted stem cells after traumatic brain injury. Restor Neurol Neurosci 30:9–19
Shear DA et al (2011) Stem cell survival and functional outcome after traumatic brain injury is dependent on transplant timing and location. Restor Neurol Neurosci 29:215–225
Lee DH et al (2013) Functional recovery after injury of motor cortex in rats: effects of rehabilitation and stem cell transplantation in a traumatic brain injury model of cortical resection. Childs Nerv Syst 29:403–411
Giraldi-Guimaraes A et al (2012) Bone marrow mononuclear cells and mannose receptor expression in focal cortical ischemia. Brain Res 1452:173–184
Chuang TJ et al (2012) Effects of secretome obtained from normoxia-preconditioned human mesenchymal stem cells in traumatic brain injury rats. J Trauma Acute Care Surg 73:1161–1167
Walker PA et al (2012) Bone marrow-derived stromal cell therapy for traumatic brain injury is neuroprotective via stimulation of non-neurologic organ systems. Surgery 152:790–793
Tu Y et al (2012) Combination of temperature-sensitive stem cells and mild hypothermia: a new potential therapy for severe traumatic brain injury. J Neurotrauma 29:2393–2403
Antonucci I et al (2012) Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. Curr Pharm Des 18:1846–1863
Joo KM et al (2012) Trans-differentiation of neural stem cells: a therapeutic mechanism against the radiation induced brain damage. PLoS One 7:e25936
Shi W et al (2012) BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials 33:3119–3126
Yang L et al (2011) Transplantation of Schwann cells differentiated from adipose-derived stem cells modifies reactive gliosis after contusion brain injury in rats. J Int Med Res 39:1344–1357
Skardelly M et al (2011) Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury. J Neurotrauma 28:401–414
Reiss P, Zhang C, Saatman KE (2002) Transplanted neural cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 51:1043–1052
Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC (2002) Human bone marrow cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174:11–20
Peled A, Kollet O, Ponomaryov T, Petit I, Frantza S, Grabovsky V et al (2000) The chemokine SDF-1 activated the integrins LFA-1, VLA-4, and VLA-5 on immature CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95:3289–3296
Yamaguichi J, Kusano K, Masuo O, Kawamoto A, Silver M, Murasawa S et al (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322–1328
Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109:337–346
Rajantie L, Llmonen M, Alminaite A, Ozer U, Alitalo K, Salven P (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104:2084–2086
Lu D, Mahmood A, Qu C, Goussev A, Schallert T, Chopp M (2005) Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22:1011–1017
Sun D, Mcginn MJ, Zhou Z, Harvey HB, Bullock MR, Colello RJ (2007) Anatomical integration of newly generated dentate granule neurons following traumatic brain injury in adult rats and its association to cognitive recovery. Exp Neurol 204:264–272
Guo X, Liu L, Zhang M, Bergeron A, Cui Z, Dong JF, Zhang J (2009) Correlation of CD34+ cells with tissue angiogenesis after traumatic brain injury in a rat model. J Neurotrauma 26:1337–1344
Madeddu P (2005) Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 90:315–326
Besler C, Doerries C, Giannotti G, Lüscher TF, Landmesser U (2008) Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev Cardiovasc Ther 6:1071–1082
Mahmoud A, Lu D, Chopp M (2004) Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors after traumatic brain injury. J Neurotrauma 21:33–39
Suarez-Monteagudo C, Hernandez-Ramirez P, Alvarez-Gonzalez L, Garcia-Maeso I, de la Cuetara-Bernal K, Castillo-Diaz L et al (2009) Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor Neurol Neurosci 27:151–161
Borlongan CV (2009) Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke 40:146–148
Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL et al (2008) Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab 28:217–219
Santiago LA, Oh BC, Dash PK, Holcomb JB, Wade CE (2012) A clinical comparison of penetrating and blunt traumatic brain injuries. Brain Inj 26:107–125
Manley GT, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, Veenstra TD, Ling G, Ottens AK, Tortella F, Hayes RL (2010) Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch Phys Med Rehabil 91:1667–1672
Keene CD, Ortiz-Gonzalez XR, Jiang Y, Largaespada DA, Verfaillie CM, Low WC (2003) Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant 2:201–213
Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al (2002) Human bone marrow stromal cells suppress T lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838–3843
Jorgensen C, Djouad F, Apparailly F (2003) Engineering mesenchymal stem cells for immunotherapy. Gene Ther 10:928–931
Le Blanc K, Tammik L, Sundberg B, Haynesworth SE et al (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the MHC. Scand J Immunol 57:11–20
McIntosh K, Bartholomew A (2000) Stromal cell modulation of the immune system: a potential role for mesenchymal stem cells. Graft 3:324–328
Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822
Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications for transplantation. Transplantation 75:389–397
Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1411–1412
Reyes M, Verfaillie CM (2001) Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 938:231–233, discussion; 233–5
Ayata C, Ropper AH (2002) Ischaemic brain edema. J Clin Neurosci 9:113–124
Busch E, Kruger K, Fritze K, Allegrini PR, Hoehn-Berlage M, Hossmann KA (1997) Blood–brain barrier disturbances after rt-PA treatment of thromboembolic stroke in the rat. Acta Neurochir Suppl 70:206–208
Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM (2004) The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 24:945–963
De Brouns R, Deyn PP (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111:483–495
Aoki T, Sumii T, Mori T, Wang X, Lo EH (2002) Blood–brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33:2711–2717
Subramaniam S, Hill MD (2009) Decompressive hemicraniectomy for malignant middle cerebral artery infarction: an update. Neurologist 15:178–184
Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P et al (2003) Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34:558–564
Castillo J, Alvarez-Sabin J, Martinez-Vila E, Montaner J, Sobrino T, Vivancos J (2009) MITICO study investigators. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol 256:217–224
Vila N, Castillo J, Davalos A, Chamorro A (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31:2325–2329
Castillo J, Leira R (2002) Predictors of deteriorating cerebral infarct: role of inflammatory mechanisms. Would its early treatment be useful? Cerebrovasc Dis 1:40–48
Doyle KP, Simon RP, Stenzel-Poore MP (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55:310–318
Wang GJ, Deng HY, Maier CM, Sun GH, Yenari MA (2002) Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke. Neuroscience 114:1081–1090
Tang Y, Xu H, Du X, Lit L, Walker W, Lu A et al (2006) Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 26:1089–1102
Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I (2011) Blood–brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol 2011:765923
Dietrich WD, Alonso O, Halley M (1994) Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma 11:289–301
Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR (2010) Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J Cereb Blood Flow Metab 30:1008–1016
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ et al (2003) Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108:2710–2715
Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932–936
Masuda H, Asahara T (2003) Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58:390–398
Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362–367
Bompais H, Chagraoui J, Canron X, Crisan M, Liu XH, Anjo A et al (2004) Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 103:2577–2584
Fadini GP (2008) An underlying principle for the study of circulating progenitor cells in diabetes and its complications. Diabetologia 51:1091–1094
Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH (2004) Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci 107:273–280
Pirro M, Schillaci G, Menecali C, Bagaglia F, Paltriccia R, Vaudo G et al (2007) Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens 25:2093–2099
Umemura T, Soga J, Hidaka T, Takemoto H, Nakamura S, Jitsuiki D et al (2008) Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am J Hypertens 21:1203–1209
Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C et al (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54:2605–2615
Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y (2004) Defective vasculogenesis in systemic sclerosis. Lancet 364:603–610
Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C (2005) Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45:1441–1448
Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S et al (2004) Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24:1442–1447
Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A (2006) Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 187:423–432
Botta R, Gao E, Stassi G, Bonci D, Pelosi E, Zwas D et al (2004) Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34 + KDR + cells. FASEB J 18:1392–1394
Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H et al (2001) Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103:634–637
Madeddu P, Emanueli C, Pelosi E, Salis MB, Cerio AM, Bonanno G et al (2004) Transplantation of low dose CD34 + KDR + cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 18:1737–1739
van Rouhl RP, Oostenbrugge RJ, Damoiseaux J, Cohen Tervaert JW, Lodder J (2008) Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 39:2158–2165
Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, Emmrich F et al (2005) Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97:756–762
Li ZQ, Zhang M, Jing YZ, Zhang WW, Liu Y, Cui LJ et al (2007) The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol 115:52–56
Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, de la Penarrubia MJ, Fuente L et al (2004) Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95:742–748
Meluzin J, Janousek S, Mayer J, Groch L, Hornacek I, Hlinomaz O et al (2008) Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. Int J Cardiol 128:185–192
Meluzin J, Mayer J, Groch L, Janousek S, Hornacek I, Hlinomaz O et al (2006) Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 152:975
Mocini D, Staibano M, Mele L, Giannantoni P, Menichella G, Colivicchi F et al (2006) Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. Am Heart J 151:192–197
Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT et al (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294–2302
Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV et al (2004) Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110:213–218
Strauer BE, Brehm M, Zeus T, Bartsch T, Schannwell C, Antke C et al (2005) Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT study. J Am Coll Cardiol 46:1651–1658
Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV et al (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913–1918
Numaguchi Y, Sone T, Okumura K, Ishii M, Morita Y, Kubota R et al (2006) The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 114:114–119
Dobert N, Britten M, Assmus B, Berner U, Menzel C, Lehmann R et al (2004) Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with fdg-pet and thallium spect. Eur J Nucl Med Mol Imaging 31:1146–1151
Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z (2005) Circulating endothelial progenitor cells and coronary collaterals in patients with non-st segment elevation myocardial infarction. J Vasc Res 42:408–414
Hristov M, Heussen N, Schober A, Weber C (2006) Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med 10:727–733
Dimmeler S, Zeiher AM, Schneider MD (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115:572–583
Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K et al (2004) Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 109:1215–1218
Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K et al (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427–435
Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K et al (2004) Circulating cd34-positive cells provide an index of cerebrovascular function. Circulation 109:2972–2975
Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T et al (2005) Endothelial progenitor cells during cerebrovascular disease. Stroke 36:151–153
Menge T, Zhao Y, Zhao J, Wataha K, Gerber M, Zhang J, Letourneau P, Redell J, Shen L, Wang J, Peng Z, Xue H, Kozar R, Cox CS, Khakoo AY, Holcomb JB, Dash PK, Pati S (2012) Mesenchymal stem cells regulate blood–brain barrier integrity through timp3 release after traumatic brain injury. Sci Transl Med 4:161ra150
Jujo K, Ii M, Losordo DW (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45:530–544
Disclosures/Conflict of Interests: CVB is supported by NIH NINDS 5U01NS055914-04 and NIH NINDS R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, and receives research grant support for his projects on bone marrow stem cell therapy for stroke from SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pabón, M.M. et al. (2014). Stem Cells for Neurovascular Repair in CNS Trauma. In: Lo, E., Lok, J., Ning, M., Whalen, M. (eds) Vascular Mechanisms in CNS Trauma. Springer Series in Translational Stroke Research, vol 5. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8690-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8690-9_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8689-3
Online ISBN: 978-1-4614-8690-9
eBook Packages: MedicineMedicine (R0)